REPLY
Concept Reply, part of the Reply network of companies and specialised in IoT, is working with MULTIVAC, a leading manufacturer of processing and packaging solutions, to develop smart services for automated machine monitoring. This project is part of the Open Industry 4.0 Alliance initiative, in which industry-specific companies have joined forces to develop common standards for the transformation to the Industrial Internet of Things.
As a member of the Open Industry 4.0 Alliance, Concept Reply contributes its expertise to IoT projects and actively supports the setting of standards in the field of Industrial IoT. In this context, Concept Reply is successfully working for international founding member MULTIVAC on the "smart services" project. This cloud IoT project aims to digitally manage machines - both locally and remotely - to make processes more transparent and to increase the efficiency and productivity of systems.
The cloud IoT platform implemented for MULTIVAC acts as a central monitoring and management instance. The data is processed on the platform and made available to users as smart services in freely configurable dashboards. The use of a micro-front-end architecture on the Azure cloud and the application of modern web technologies form the basis for the future use of AI-based assistants, thus laying the foundation for new business models and a sustainable, resource-efficient smart factory. The combination of cloud & edge computing reduces latency from data acquisition to sensor technology and actuator control. The benefits for the user are real-time data processing, protection against cyber-attacks and direct machine-to-machine communication.
Further projects with MULTIVAC are already in the pipeline to expand industry standards through the intelligent digitalisation of production and to actively shape the future of Industry 4.0. Dr Marius Grathwohl, VP Digital Products and Transformation at MULTIVAC and Member of the Board of the Alliance, concluded: "The successful collaboration between Concept Reply and MULTIVAC is based on the commonality of an open mindset and a shared understanding of Industry 4.0. Both companies are members of the Open Industry 4.0 Alliance, and we already have a common understanding of the architecture".
Together with its members, the Open Industry 4.0 Alliance is developing multi-vendor Industry 4.0 solutions and services for automated production systems and warehouses. Use cases include automated onboarding, device provisioning, device management, digital nameplates, digital twins and automated device lifecycle management. The open technical ecosystems enable machines and applications from different vendors to be networked and data to be securely transported along the value chain.
Reply
Reply [EXM, STAR: REY] specialises in the design and implementation of solutions based on new communication channels and digital media. As a network of highly specialised companies, Reply defines and develops business models enabled by the new models of AI, big data, cloud computing, digital media and the internet of things. Reply delivers consulting, system integration and digital services to organisations across the telecom and media; industry and services; banking and insurance; and public sectors. www.reply.com
Concept Reply
Concept Reply is an IoT software developer specializing in the research, development and validation of innovative solutions and supports its customers in the automotive, manufacturing, smart infrastructure and other industries in all matters relating to the Internet of Things (IoT) and cloud computing. The goal is to offer end-to-end solutions along the entire value chain: from the definition of an IoT strategy, through testing and quality assurance, to the implementation of a concrete solution. www.concept.reply.com
MULTIVAC Group
Bundled expertise, innovative top technology and strong brands under one roof: The MULTIVAC Group offers complete solutions for the packaging and processing of food, medical and pharmaceutical products as well as industrial goods - and continues to set new standards in the market as a technology leader. For more than 60 years, the name has stood for stability and values, innovation and sustainability, quality and excellent service. Founded in 1961 in the Allgäu region of Germany, the MULTIVAC Group is now a global solutions provider that helps small and medium-sized companies as well as large corporations to organise their production processes efficiently and in a way that conserves resources. www.multivac.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231220017040/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Enginzyme and AGC Create Scalable Process for Key mRNA Ingredient12.1.2026 06:00:00 CET | Press release
At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5'-triphosphate (m¹ΨTP). The rapid growth of mRNA-based vaccines and therapeutics has driven significant demand for modified nucleotides like m¹ΨTP, which enhances mRNA stability and expression, while reducing immunogenicity. Enginzyme is a deep-tech company delivering optimized biomanufacturing solutions through cell-free enzyme engineering technology. AGC Inc. is a leading global player in fields spanning from architectural glass to chemicals and life science. AGC Inc. provides services in a wide range of life science fields, from synthetic pharmaceuticals and agrochemicals, to biopharmaceuticals and leading-edge cell and gene therapies, as well as messenger RNAs. The presentation in November detailed the latest collaboration between the companies, with a focus on the biomanufacturing of nucleotides for mRNA therapy,
Ant International Partners with Google’s Universal Commerce Protocol to Expand AI Capabilities12.1.2026 02:15:00 CET | Press release
Ant International, a leading global payment, digitisation, and financial technology provider, is collaborating on the launch of Google’s Universal Commerce Protocol (UCP), a new open standard for agentic commerce that works across the entire shopping journey — from discovery and buying to post-purchase support. UCP establishes a common language for agents and systems to operate together across consumer surfaces, businesses, and payment providers to enable commerce. So instead of requiring unique connections for every individual agent, UCP enables all agents to interact easily. UCP is built to work across verticals and is compatible with existing industry protocols like Agent2Agent (A2A), Agent Payments Protocol (AP2), and Model Context Protocol (MCP). “For agentic commerce to scale, it’s critical for the industry to align on a common set of standards. We are proud to have Ant International endorse the Universal Commerce Protocol as the foundation for that future,” said Ashish Gupta, VP
Torq Secures $140M Series D at $1.2B Valuation to Lead the AI SOC and Agentic AI Era11.1.2026 17:59:00 CET | Press release
Fueled by Massive Customer Adoption of AI Agents, Torq Scales the World’s First True AI SOC Platform and Accelerates Expansion into the U.S. Federal Market Torq, the established Agentic AI security operations pioneer, today announced it has closed a massive $140 million Series D funding round, propelling its valuation to $1.2 billion and total funding to $332M. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112510774/en/ Led by Merlin Ventures—a leading cybersecurity fund renowned for its deep access to the U.S. commercial and Public Sector markets—with participation from all existing investors, including Evolution Equity Partners, Notable Capital, Bessemer Venture Partners, Insight Ventures Partners, and Greenfield Partners, this capital injection is a definitive investment in the future of security. Torq is driving the industry’s critical shift: the complete transformation of the Security Operations Center (SOC) through
Andersen udvider sine kompetencer med tilføjelsen af Scimitar9.1.2026 21:44:00 CET | Pressemeddelelse
Andersen Consulting har indgået en samarbejdsaftale med Scimitar, der er et firma med fokus på at accelerere innovation i biovidenskabsbranchen. Scimitar, der har hovedkvarter i USA, et førende konsulenthus inden for strategieksekvering for biovidenskabsbranchen. Virksomheden er specialiseret i design af driftsmodeller, digital transformation og organisatorisk forandring. Scimitar samarbejder med medicinal- og biotech-virksomheder om at accelerere innovation, styrke den driftsmæssige eksekvering og sikre compliance gennem hele produkters livscyklus. Deres praktiske og samarbejdsorienterede tilgang sikrer løsninger, der ikke blot er formålstjenlige, men også skalerbare. "Virksomheder inden for biovidenskabsbranchen befinder sig i en tid med hurtige videnskabelige fremskridt, stigende regulatorisk kompleksitet og et voksende behov for operationel agilitet, samtidig med at de holdes op mod de højeste standarder for patientsikkerhed og dataintegritet," udtaler Ramy Khalil, CEO i Scimitar.
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 13:00:00 CET | Press release
Expanded collaboration builds on Acepodia and Biocytogen’s recent co-development efforts to evaluate selected bispecific antibody and dual-payload ADC programs Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreem
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom